[Adipocytes, adipokines and metabolic alterations in pulmonary fibrosis]

Rev Mal Respir. 2023 Mar;40(3):225-229. doi: 10.1016/j.rmr.2023.01.016. Epub 2023 Feb 4.
[Article in French]

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal respiratory disease characterized by severe remodeling of the lung parenchyma, with an accumulation of activated myofibroblasts and extracellular matrix, along with aberrant cellular differentiation. Within the subpleural fibrous zones, ectopic adipocyte deposits often appear. In addition, alterations in lipid homeostasis have been associated with IPF pathophysiology. In this mini-review, we will discuss the potential involvement of the adipocyte secretome and its paracrine or endocrine-based contribution to the pathophysiology of IPF, via protein or lipid mediators in particular.

Keywords: Adipocytes; Adipokines; Fibrose pulmonaire idiopathique; Idiopathic pulmonary fibrosis; Metabolic syndrome; Syndrome métabolique.

Publication types

  • Review
  • English Abstract

MeSH terms

  • Adipocytes / metabolism
  • Adipokines*
  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Lipids
  • Lung

Substances

  • Adipokines
  • Lipids